Loading...
XIDX
PRIM
Market cap14mUSD
Nov 12, Last price  
80.00IDR
Name

Royal Prima Tbk PT

Chart & Performance

D1W1MN
XIDX:PRIM chart
P/E
—
P/S
0.80
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.09%
Rev. gr., 5y
5.40%
Revenues
338.91b
+13.21%
16,652,338,31472,736,511,686137,921,372,382177,595,506,808204,794,915,533174,217,486,000260,590,703,000599,963,837,000261,933,014,000265,336,922,000299,357,331,000338,906,097,000
Net income
-21.82b
L+18.52%
-2,303,998,4501,827,224,24611,544,591,34320,198,647,74417,205,025,2792,396,701,00038,169,752,00075,433,539,00021,589,057,000-2,746,502,000-18,407,912,000-21,817,385,000
CFO
4.14b
-91.19%
3,678,362,924-4,729,631,36828,017,879,68022,217,087,77735,333,956,4372,983,278,00060,164,661,847234,535,188,45521,589,057,00021,267,436,00046,982,346,0004,138,350,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Royal Prima Tbk, headquartered in Jakarta, Indonesia, delivers healthcare services across the nation. The company manages hospitals operating under the distinct brands of Royal Prima Medan and Royal Prima Jambi. This enterprise was established in 2013.
URL
https://www.royalprima.com/
IPO date
May 15, 2018
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑112016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT